Impact and Biological Necessity
Bone Fractures can lead to a major deterioration of a person’s quality of life as a result of the persistence of chronic pain and reduced ability to perform daily activities. Many orthopedic trauma cases present as complex fractures and problematic complications, such as delayed or non-unions, which can take years to resolve. Complications of trauma place a significant burden on patients and their families, physically, psychologically and financially. Many of these patients have limited options as traditional orthopedic techniques and surgery often fall short in the management of complex trauma cases. This has fueled the search for novel regenerative strategies utilizing UC-MSCs. There is an increasing consensus within the medical community on the importance and timeliness of the role of new biological strategies for the resolution of significant healing impasses. These innovations in cellular based approaches are structurally and functionally novel and amongst them offer unrivalled regenerative potential. For this reason, many patients are searching for new scientific alternatives, and stem cell therapy Thailand has emerged as a leading destination for these therapies.
Biological Mechanisms
The repair of Bone Fractures involves a complex series of biological processes including inflammation, formation of a soft callus, hard callus and remodeling of bone. The central role of bone healing is the recruitment and differentiation of mesenchymal stem cells, such as UC-MSCs, and progenitors into osteoblasts. During the normal healing and regeneration of tissue, there is the migration of stem cells to the site of injury and they respond to distress signals in a molecular and cellular form. The stem cells are then prompted to synthesize the framework (extracellular matrix) of bone and they undergo the process of mineralization of the matrix. The process of bone formation is largely dependent on the expression of the RUNX2 transcription factor. In complex fractures, the physiological processes of bone healing and regeneration are inadequate, which is where stem cell therapy Thailand offers new hope.
Stem cell therapy Thailand is introducing the use of UC-MSCs in the treatment of microenvironment deficiencies in Bone Fractures. These therapeutic stem cells undergo the process of endochondral ossification to complete the fracture matrix. In addition, they begin a succession of local signaling pathways by releasing morphogens that activate nearby osteoprogenitor cells. This combined trophic support accelerates the replacement of the cartilaginous callus with bone.
Limitations of Current Treatments
Contemporary orthopedics employs a variety of stabilization techniques, often involving casting or fixative devices. One of the techniques, Open Reduction/Internal Fixation, is used to realign and stabilize fractured bones. Structural deficiencies at the fracture site are augmented by the provision of an autogenous bone graft. Although these practices remain the standard, there are serious physiological consequences. Internal fixation devices may cause deep tissue infection, hardware failure, and chronic irritation. Bone grafting causes prolonged discomfort to the donor site with impaired healing. Despite the presence of a biological deficit of UC-MSCs in cases of critical healing, these stabilization techniques offer no viable solution. Given that most mechanical stabilization techniques are predicated on internal fixation devices, the demand for stem cell therapy Thailand will remain given the lack of biological cell requirements for compromised healing.
The Need for Advanced Therapies
The shift from mechanical restorations to biological repairs for Bone Fractures explains the interest in UC-MSCs within the field of stem cell therapy Thailand. They are harvested from the Wharton’s jelly of umbilical cords and offer a high potential of proliferation compared to other sources of MSCs. In the context of stem cell therapy Thailand, their special features of the immune system permit safe allogeneic administration while avoiding systemic immune rejection. When introduced to Complex Non-Healing Bone Fractures, UC-MSCs have remarkable localized functions of immune system modulation. They modify the hyper-inflammatory destructive micro-environment to a healing environment by changing the cellular polarization of macrophages. In addition to immune system modulation, the strong secretome of UC-MSCs has potent and specific angiogenic factors, such as Vascular Endothelial Growth Factor. This provides important and rapid formation of new blood vessels necessary to supply the fracture healing zone with nutrients and oxygen, as well as to remove waste. The localized, specific, and rapid release of extracellular vesicles prevents the formation of fibrosis and ensures that the regenerating fracture healing zone becomes solid and functional bone.
Figure 1: Limitations of current treatments and advanced therapy with UC-MSCs in Bone Fractures
The Trajectory of Regenerative Solutions
The developing global geopolitical landscape of medicine has provided Southeast Asia with an advantageous opportunity to rapidly develop Regenerative Medicine. An increasing number of international patients are attracted to stem cell therapy Thailand for treating Bone Fractures. The country has excellent medical facilities with orthopedic surgeons and researchers with specialized training. The country has excellent facilities that have invested in the safety of clinical practices. The country has improved the quality of research. The successful application of UC-MSCs to severe skeletal injury requires an excellent sterile research laboratory and the capabilities to cultivate and control the quality of the research. The facilities in the region have these capabilities. stem cell therapy Thailand utilizes the positive and attractive regulatory provisions of the Thai Government to take the lead in the rapid movement of UC-MSCs based treatments from lab-based research to clinical use in comparison to other countries. As a result, stem cell therapy is becoming a viable, competitive, and accessible therapy to patients in need of advanced solutions to the biological resolution of Bone Fractures.